ProCure Proton Therapy Center opens in Oklahoma
A ProCure Proton Therapy Center for the treatment of cancer patients opened Wednesday in Oklahoma City, Okla.
Patients with head and neck, brain, central nervous system, prostate and some pediatric cancers, among others, will be treated at the new center. The ProCure Proton Therapy Center is the sixth such center in operation in the United States, and the first center to open since 2006, the firm said.
The Procure Proton Therapy Center is affiliated with Integris Health, a Oklahoma-owned, not-for-profit health system. Integris is opening the Cancer Institute of Oklahoma adjacent to the proton therapy center and will provide treatment and services to patients who may need additional care while undergoing proton therapy.
At the opening, ProCure's CEO Hadley Ford acknowledged philanthropist Aubrey K. McClendon--the co-founder, chairman and CEO of Oklahoma City-based Chesapeake Energy--who provided the initial $70 million funding for ProCure.
The 60,000-square-foot center will have four treatment rooms with a treatment capacity of 1,500 patients a year.
Patients with head and neck, brain, central nervous system, prostate and some pediatric cancers, among others, will be treated at the new center. The ProCure Proton Therapy Center is the sixth such center in operation in the United States, and the first center to open since 2006, the firm said.
The Procure Proton Therapy Center is affiliated with Integris Health, a Oklahoma-owned, not-for-profit health system. Integris is opening the Cancer Institute of Oklahoma adjacent to the proton therapy center and will provide treatment and services to patients who may need additional care while undergoing proton therapy.
At the opening, ProCure's CEO Hadley Ford acknowledged philanthropist Aubrey K. McClendon--the co-founder, chairman and CEO of Oklahoma City-based Chesapeake Energy--who provided the initial $70 million funding for ProCure.
The 60,000-square-foot center will have four treatment rooms with a treatment capacity of 1,500 patients a year.